CD8+ TRM cells also express chemokines like CXCR6, which promotes cell retention in the tumor sites and unleash effector functions in ovarian cancer (Muthuswamy et al., 2021a; Muthuswamy et al., 2021b). Here, CD8A is linked to neoplasm.